SB

Samsara BioCapital Portfolio holdings

AUM $766M
1-Year Est. Return 329.84%
This Quarter Est. Return
1 Year Est. Return
+329.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$484M
AUM Growth
+$19.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$70.8M
2
+$6.87M
3
+$3.67M
4
INZY
Inozyme Pharma
INZY
+$2.89M
5
CYPH
Cypherpunk Technologies Inc
CYPH
+$288K

Top Sells

1
+$2.95M
2
+$2.16M
3
+$1.47M
4
SWTX
SpringWorks Therapeutics
SWTX
+$578K
5
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$153K

Sector Composition

1 Healthcare 99.94%
2 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$3.42M 0.71%
495,000
27
$2.89M 0.6%
+504,407
28
$2.63M 0.54%
196,425
29
$2.49M 0.51%
630,000
30
$2.42M 0.5%
801,629
31
$2.4M 0.5%
202,348
32
$2.35M 0.49%
881,450
33
$2.13M 0.44%
154,664
34
$1.89M 0.39%
1,008,437
35
$1.58M 0.33%
830,565
36
$1.46M 0.3%
52,458
37
$1.41M 0.29%
480,000
38
$1.32M 0.27%
40,888
39
$1.19M 0.25%
262,786
40
$1.18M 0.24%
89,414
41
$1.1M 0.23%
689,709
42
$766K 0.16%
172,089
43
$449K 0.09%
615,541
44
$333K 0.07%
25,000
45
$324K 0.07%
3,580
46
$300K 0.06%
262,827
-134,008
47
$288K 0.06%
+84,604
48
$256K 0.05%
35,349
49
$253K 0.05%
45,000
50
$181K 0.04%
12,024
1
2
3